Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population

Breast Cancer Research and Treatment

Volumn 137, Issue 2, 2013, Pages 559-569

  Jara, Lilian ^a   Gonzalez Hormazabal, Patricio ^a   Cerceño, Kerube ^a   Di Capua, Gabriella A ^a   Reyes, Jose M ^b   Blanco, Rafael ^a   Bravo, Teresa ^c   Peralta, Octavio ^a,b   Gomez, Fernando ^d   Waugh, Enrique ^d   Margarit, Sonia ^e   Ibañez, Gladys ^f,g   Romero, Carmen ^h   Pakomio, Janara ^a   Roizen, Gigia ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b CLÍNICA LAS CONDES   (Chile)

^c National Cancer Society Corporacion Nacional del Cancer CONAC   (Chile)

^d CLÍNICA SANTA MARÍA   (Chile)

^e UNIVERSIDAD DEL DESARROLLO   (Chile)

^f Section of Gastroenterology   (Chile)

^g HOSPITAL SAN JOSÉ   (Chile)

^h HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Breast cancer; FGFR2; MAP3K1; Polymorphism

Indexed keywords

CYTOSINE; FIBROBLAST GROWTH FACTOR RECEPTOR 2; GUANINE; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 1; THYMINE; FGFR2 PROTEIN, HUMAN; MAP3K1 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC GROUP; FAMILIAL CANCER; FEMALE; FGFR2 GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MAP3K1 GENE; NON FAMILIAL EARLY ONSET BREAST CANCER; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH AMERICAN; BREAST TUMOR; CASE CONTROL STUDY; CHILE; FAMILY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; ONSET AGE;

ADULT; AGE OF ONSET; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHILE; FAMILY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MAP KINASE KINASE KINASE 1; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2;

MLCS; MLOWN;

EID: 84880634849     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2359-z     Document Type: Article

References (38)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10-29. doi: 10.3322/caac.20138
2. Departamento de Estadísticas e Información en Salud (2009) Defunciones por tumores malignos según sexo, chile 2000-2009. [ http://deis.minsal.cl/vitales/defunciones-serie/Defunciones-Mortalidad-Tumores- Malignos-edad-2000-2009.htm ] Accessed 15 Sep 2012
3. Stratton MR, Rahman N (2008) The emerging landscape of breast cancer susceptibility. Nat Genet 40:17-22. doi: 10.1038/ng.2007.53.2
4. Pharoah PDP, Antoniou AC, Easton DF, Ponder BAJ (2008) Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med 358:2796-2803. doi: 10.1056/NEJMsa0708739
5. Easton DF, Pooley KA, Dunning AM, Pharoah PDP, Thompson D, Ballinger DG et al (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447:1087-1093. doi: 10.1038/nature05887
6. Wesche J, Haglund K, Haugsten EM (2011) Fibroblast growth factors and their receptors in cancer. Biochem J 437:199-213. doi: 10.1042/BJ20101603
7. Penault-Llorca F, Bertucci F, Adélaïde J, Parc P, Coulier F, Jacquemier J et al (1995) Expression of FGF and FGF receptor genes in human breast cancer. Int J Cancer 61:170-176. doi: 10.1002/ijc.2910610205
8. Koziczak M, Holbro T, Hynes NE (2004) Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins. Oncogene 23:3501-3508. doi: 10.1038/sj.onc.1207331
9. Ingersoll RG, Paznekas WA, Tran AK, Scott AF, Jiang G, Jabs EW (2001) Fibroblast growth factor receptor 2 (FGFR2): genomic sequence and variations. Cytogenet Cell Genet 94:121-126. doi: 10.1159/000048802
10. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE et al (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39:870-874. doi: 10.1038/ng2075
11. Huijts PEA, Vreeswijk MPG, Kroeze-Jansema KHG, Jacobi CE, Seynaeve C, Krol-Warmerdam EMM et al (2007) Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a dutch cohort of incident breast cancer cases. Breast Cancer Res 9:R78. doi: 10.1186/bcr1793
12. Liang J, Chen P, Hu Z, Zhou X, Chen L, Li M et al (2008) Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women. Carcinogenesis 29:2341-2346. doi: 10.1093/carcin/bgn235
13. Raskin L, Pinchev M, Arad C, Lejbkowicz F, Tamir A, Rennert HS et al (2008) FGFR2 is a breast cancer susceptibility gene in Jewish and Arab Israeli populations. Cancer Epidemiol Biomarkers Prev 17:1060-1065. doi: 10.1158/1055-9965.EPI-08-0018
14. Meyer KB, Maia A, O'Reilly M, Teschendorff AE, Chin S, Caldas C et al (2008) Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer. PLoS Biol 6:e108. doi: 10.1371/journal.pbio.0060108
15. Hemminki K, Müller-Myhsok B, Lichtner P, Engel C, Chen B, Burwinkel B et al (2010) Low-risk variants FGFR2, TNRC9 and LSP1 in german familial breast cancer patients. Int J Cancer 126:2858-2862. doi: 10.1002/ijc.24986
16. Barnholtz-Sloan JS, Shetty PB, Guan X, Nyante SJ, Luo J, Brennan DJ et al (2010) FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in african-american and younger women. Carcinogenesis 31:1417-1423. doi: 10.1093/carcin/bgq128
17. Jia C, Cai Y, Ma Y, Fu D (2010) Quantitative assessment of the effect of FGFR2 gene polymorphism on the risk of breast cancer. Breast Cancer Res Treat 124:521-528. doi: 10.1007/s10549-010-0872-5
18. Fu F, Wang C, Huang M, Song C, Lin S, Huang H (2012) Polymorphisms in second intron of the FGFR2 gene are associated with the risk of early-onset breast cancer in Chinese Han women. Tohoku J Exp Med 226:221-229. doi: 10.1620/tjem.226.221
19. Garcia-Closas M, Chanock S (2008) Genetic susceptibility loci for breast cancer by estrogen receptor status. Clin Cancer Res 14:8000-8009. doi: 10.1158/1078-0432.CCR-08-0975
20. Slattery ML, Baumgartner KB, Giuliano AR, Byers T, Herrick JS, Wolff RK (2011) Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-hispanic white women living in the southwestern united states. Breast Cancer Res Treat 129:531-539. doi: 10.1007/s10549-011-1498-y
21. Lu P, Yang J, Li C, Wei M, Shen W, Shi L et al (2011) Association between mitogen-activated protein kinase kinase kinase 1 rs889312 polymorphism and breast cancer risk: evidence from 59,977 subjects. Breast Cancer Res Treat 126:663-670. doi: 10.1007/s10549-010-1151-1
22. Gonzalez-Hormazabal P, Gutierrez-Enriquez S, Gaete D, Reyes JM, Peralta O, Waugh E et al (2011) Spectrum of BRCA1/2 point mutations and genomic rearrangements in high-risk breast/ovarian cancer Chilean families. Breast Cancer Res Treat 126:705-716. doi: 10.1007/s10549-010-1170-y
23. Jara L, Ampuero S, Santibáñez E, Seccia L, Rodríguez J, Bustamante M et al (2006) BRCA1 and BRCA2 mutations in a South American population. Cancer Genet Cytogenet 166:36-45. doi: 10.1016/j.cancergencyto.2005. 08.019
24. Körkkö J, Annunen S, Pihlajamaa T, Prockop DJ, Ala-Kokko L (1998) Conformation sensitive gel electrophoresis for simple and accurate detection of mutations: comparison with denaturing gradient gel electrophoresis and nucleotide sequencing. Proc Natl Acad Sci USA 95:1681-1685. doi: 10.1073/pnas.95.4.1681
25. Chomczynski P, Sacchi N (2006) The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat Protoc 1:581-585. doi: 10.1038/nprot.2006.83
26. Dudbridge F (2008) Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 66:87-98. doi: 10.1159/000119108
27. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265. doi: 10.1093/bioinformatics/bth457
28. Rothman KL (1986) Modern epidemiology. Little Brown & Co, Boston
29. Hosmer DW, Lemeshow S (1992) Confidence interval estimation of interaction. Epidemiology 3:452-456
30. Zhou L, Yao F, Luan H, Wang Y, Dong X, Zhou W et al (2012) Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis. Breast Cancer Res Treat. doi: 10.1007/s10549-012-2300-5
31. Udler MS, Meyer KB, Pooley KA, Karlins E, Struewing JP, Zhang J et al (2009) FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. Hum Mol Genet 18:1692-1703. doi: 10.1093/hmg/ddp078
32. Gold B, Kirchhoff T, Stefanov S, Lautenberger J, Viale A, Garber J et al (2008) Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci USA 105:4340-4345. doi: 10.1073/pnas.0800441105
33. Chen F, Lv M, Xue Y, Zhou J, Hu F, Chen X et al (2012) Genetic variants of fibroblast growth factor receptor 2 (FGFR2) are associated with breast cancer risk in Chinese women of the Han nationality. Immunogenetics 64:71-76. doi: 10.1007/s00251-011-0564-2
34. Esteban Cardeñosa E, de Juan Jiménez I, Palanca Suela S, Chirivella González I, Segura Huerta A, Santaballa Beltran A et al (2012) Low penetrance alleles as risk modifiers in familial and sporadic breast cancer. Fam Cancer 11:629-636. doi: 10.1007/s10689-012-9563-1
35. Cruz-Coke R (1976) Origen y evolución étnica de la población chilena. Rev Med Chil 104:365-368
36. Valenzuela C, Harb Z (1977) Socioeconomic assortative mating in Santiago, Chile: as demonstrated using stochastic matrices of mother-child relationships applied to abo blood groups. Soc Biol 24:225-233
37. Latif A, Hadfield KD, Roberts SA, Shenton A, Lalloo F, Black GCM et al (2010) Breast cancer susceptibility variants alter risks in familial disease. J Med Genet 47:126-131. doi: 10.1136/jmg.2009.067256
38. Malone KE, Daling JR, Neal C, Suter NM, O'Brien C, Cushing-Haugen K et al (2000) Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases. Cancer 88:1393-1402. doi: 10.1002/(SICI)1097- 0142(20000315)88:6<1393:AID-CNCR17>3.0.CO;2-P